News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events Caitlin E. Cox August 31, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Daily News PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives Michael O'Riordan August 02, 2024
News Conference News SCCT 2024 Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients Todd Neale July 22, 2024
News Daily News Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA L.A. McKeown July 02, 2024
News Daily News Think You Need a Statin? AHA’s Risk Calculator May Disagree Michael O'Riordan June 28, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks L.A. McKeown June 12, 2024
News Daily News As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness L.A. McKeown June 05, 2024
News Daily News Excess ApoB Linked to Increased MI, ASCVD Risk in Adults Michael O'Riordan June 04, 2024
News Daily News Statins Effective For Primary Prevention in Old and Very Old Michael O'Riordan May 29, 2024
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Daily News TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction Michael O'Riordan May 06, 2024
News Daily News Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI Michael O'Riordan May 02, 2024
News Daily News Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups Michael O'Riordan April 17, 2024